Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 144 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS

NCT02730299

Conditions
Acute Leukemia, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), +27 more
Locations
  • UCLA Los Angeles, California, United States
  • City of Hope Los Angeles, California, United States
  • Stanford University Cancer Institute Palo Alto, California, United States
  • UC San Diego Moores Cancer Center San Diego, California, United States
View all 52 locations
View Trial Details
Completed

A Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination With Ruxolitinib in Participants With Myelofibrosis

NCT03222609

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • UAB Comprehensive Cancer Cente /ID# 165464 Birmingham, Alabama, United States
  • TOI Clinical Research /ID# 222546 Cerritos, California, United States
  • City of Hope /ID# 221395 Duarte, California, United States
  • Moores Cancer Center at UC San Diego /ID# 164084 La Jolla, California, United States
View all 91 locations
View Trial Details

Related conditions